Company Overview and News

19
Analysts’ View of Limited Upside for DSW Inc. Looks Right

2018-06-05 investorplace
There’s kind of a good news/bad news split for DSW Inc. (NYSE:DSW) stock right now. Fiscal year 2018, ending January 2019, guidance appears solid, with the company projecting 4 to 14% earning-per-share growth and positive comps. DSW stock itself touched a two-year high last month just before its first-quarter earnings report.
DB DSW NKE SCVL FL SKX BOOT

2
3
4
BOOT / Boot Barn Holdings, Inc. 424B7 (Prospectus)

2018-05-21 sec.gov
Use these links to rapidly review the document Table of contents TABLE OF CONTENTS
BOOT

2
BOOT / Boot Barn Holdings, Inc. BOOT BARN HOLDINGS, INC. 8-K (Current Report)

2018-05-20 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT
BOOT

2
BOOT / Boot Barn Holdings, Inc. 424B7 (Prospectus)

2018-05-17 sec.gov
Use these links to rapidly review the document Table of contents TABLE OF CONTENTS
BOOT

17
Boot Barn (BOOT) Jumps: Stock Rises 11.7%

2018-05-17 zacks
Boot Barn Holdings, Inc. (BOOT - Free Report) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 42.5% in the past one-month time frame.
BKE BOOT TTD SMG

4
BOOT / Boot Barn Holdings, Inc. 10-K (Annual Report)

2018-05-16 sec.gov
Form 10-K Table of Contents
BOOT

2
Boot Barn's (BOOT) CEO Jim Conroy on Q4 2018 Results - Earnings Call Transcript

2018-05-16 seekingalpha
Good day, ladies and gentlemen and thank you for standing by. Welcome to the Boot Barn Holdings Fourth Quarter Fiscal Year 2018 Earnings Conference Call. As a reminder, this conference is being recorded.
BOOT

11
5 Growth Stocks to Scoop Up From Retail as GDP Rises 2.9%

2018-03-29 zacks
Brush off market volatility, here’s some good news to cherish. With unemployment rate still at a 17-year low, initial jobless claims below the psychological mark, consumer spending being impressive and government expenditure increasing, things appear to be fairly rosy for the U.S. economy. These sentiments were rekindled when the Bureau of Economic Analysis released its third and final estimate for real GDP yesterday.
BURL DG BOOT

14
RH Q4 Earnings Beat Estimates, Membership Model Bodes Well

2018-03-28 zacks
RH (RH - Free Report) posted strong fourth-quarter 2017 results, with shares gaining a solid 14.7% during after-hours trading. The new membership model — RH Members Program — is improving its brand image, streamlining operations and enhancing customer experience. The company’s efforts to redesign its supply chain network and rationalize product offerings bode well. RH reported fourth-quarter fiscal 2017 earnings per share of $1.
JWN DB GPS RH BOOT

21
What Falling Estimates & Price Mean for L Brands (LB)

2018-03-28 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.
OLED LB TEP BOOT

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to BOOT / Boot Barn Holdings, Inc. on message board site Silicon Investor.

Walgreen Boots Alliance - WBA Boots and Coots International Well Control Inc. (WEL)
The Silicon Investor Phone Booth Call the Mojave Phonebooth
Iu0027m a booted Sox (or is it Soxx?) clown... WEL: Boots u0026 Coots Intl. Well
Mainframe Entertainment (ReBoot/Beasties) WEL(Boots and Coots)
Trouble booting laptop - too cold?! Dream X..Backup/Multi Boot/Partitions/Drive letters/KOT
CUSIP: 099406100